Rebuilding a meaningful life for young people
- Official title: Acceptance and Commitment Therapy as an Intervention to Improve Quality of Life for Young Brain Tumour Survivors: An Acceptability and Feasibility Study
- Lead researcher: Dr Sophie Thomas
- Where: Queens Medical Centre, Nottingham (study based across three medical centres)
- When: Awarded March 2019, not yet started
- Cost: £221,410 over three years
- Research type: Quality of life, Clinical, Primary brain tumours, Young adults, Early stage clinical trial
- Grant round: Quality of life
What is it?
Acceptance and Commitment Therapy (ACT) is a psychological intervention with a broad focus. It incorporates aspects of other well-known therapies such as cognitive behaviour therapy and mindfulness. ACT aims to help participants build a rich and meaningful life, despite their ongoing difficulties, by encouraging increased psychological flexibility. Psychological flexibility is described as being open and in contact with the present moment, and engaging in behaviours that are consistent with an individual’s life goals.
Another important factor about ACT is that instead of avoiding painful experiences, it encourages a person to engage with these experiences, allowing them to move towards acceptance. This factor is particularly important when using this therapy to help people with a brain tumour, as they might be living with unavoidable physical and mental limitations as a result of their tumour or the treatment for it.
The research team, led by Dr Sophie Thomas, aims to assess the feasibility and acceptability of ACT to help young people, aged 11-24 years, who have survived a childhood brain tumour. Initially, they’ll recruit 72 participants and randomly assign some participants to receive ACT immediately, and some to have a delayed start. Ultimately, all participants will receive ACT by the end of the project.
The team will gather information about quality of life from the participants using both questionnaires and interviews. Then, the team will analyse their results to see how young people, clinicians and others involved found ACT as a therapy. They’ll also see if it was cost-effective.
Results from this study could make a big impact to extend the limited options for supporting childhood brain tumour survivors.
Why is it important?
Childhood brain tumour survivors have the poorest quality of life of all cancer survivors. Survival rates are slowly improving for children with brain tumours, resulting in more children growing up and living with tumour and/or treatment related side-effects. However, these long-term effects can include learning difficulties, poor memory, problems with motor control, anxiety, depression and symptoms of post-traumatic stress.
In a recent workshop exploring the research priorities of young cancer survivors, the highest priority of the participants was in gaining support to improve their wellbeing, mental health, and ability to socialise.
Dr Sophie Thomas and her team aims to address this unmet need and provide young people with tools that will help them to gain the support they need and have a better quality of life.
Who will it help?
This research has the potential to help improve the quality of life all brain tumour survivors, especially young people who often live longer with the after effects of brain tumours and their treatments.
It will improve our knowledge about the types of psychological interventions that are effective for brain tumour survivors. And it will increase awareness of the need for, and benefits of, psychological therapy for this age group. We hope this will encourage other brain tumours survivors to seek psychological support when needed.
We’re looking forward to seeing the achievements of this group when the project starts.
- The team will carefully design the structure of the trial, including creating the questionnaires and interviews.
- They’ll start recruiting participants at the three different centres: Nottingham Children’s Hospital, University Hospitals Bristol, and Great North Children's Hospital (Newcastle).
- Upon completion, they’ll report back about whether ACT is both accepted as an intervention for young brain tumour survivors, and if it’s cost-effective.
If you have any questions about this, or any of our other research projects, please contact us on firstname.lastname@example.org